Nanjing Vishee Medical Technology Co., Ltd

Symbol: 688580.SS

SHH

47.44

CNY

Market price today

  • 25.8198

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 3.23B

    MRK Cap

  • 0.01%

    DIV Yield

Nanjing Vishee Medical Technology Co., Ltd (688580-SS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.72%

Operating Profit Margin

0.31%

Net Profit Margin

0.28%

Return on Assets

0.07%

Return on Equity

0.08%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Zhiyu Wang
Full-time employees:686
City:Nanjing
Address:No. 19, Ningshuang Road
IPO:2020-07-21
CIK:

Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.715% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.306%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.282%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.071% return, is a testament to Nanjing Vishee Medical Technology Co., Ltd's adeptness in optimizing resource deployment. Nanjing Vishee Medical Technology Co., Ltd's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.080%. Furthermore, the proficiency of Nanjing Vishee Medical Technology Co., Ltd in capital utilization is underscored by a remarkable 0.083% return on capital employed.

Stock Prices

Nanjing Vishee Medical Technology Co., Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $50.96, while its low point bottomed out at $49.18. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Nanjing Vishee Medical Technology Co., Ltd's stock market.

Liquidity Ratios

Analyzing 688580.SS liquidity ratios reveals its financial health of the firm. The current ratio of 1053.40% gauges short-term asset coverage for liabilities. The quick ratio (1002.01%) assesses immediate liquidity, while the cash ratio (960.71%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio1053.40%
Quick Ratio1002.01%
Cash Ratio960.71%

Profitability Ratios

688580.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 30.79% underscores its earnings before tax deductions. The effective tax rate stands at 8.54%, revealing its tax efficiency. The net income per EBT, 91.46%, and the EBT per EBIT, 100.77%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 30.55%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin30.79%
Effective Tax Rate8.54%
Net Income per EBT91.46%
EBT per EBIT100.77%
EBIT per Revenue30.55%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 10.53, it details the span from stock purchase to revenue. The 10 days it takes to settle debts showcases its creditor relations. Meanwhile, a 10 cash conversion cycle and 899.00% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding1002
Days of Inventory Outstanding116
Operating Cycle157.09
Days of Payables Outstanding40
Cash Conversion Cycle118
Receivables Turnover8.99
Payables Turnover9.23
Inventory Turnover3.13
Fixed Asset Turnover1.35
Asset Turnover0.25

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 2.02, and free cash flow per share, -0.33, depict cash generation on a per-share basis. The cash per share value, 16.34, showcases liquidity position. A payout ratio of 0.05 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.30, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share2.02
Free Cash Flow per Share-0.33
Cash per Share16.34
Payout Ratio0.05
Operating Cash Flow Sales Ratio0.30
Free Cash Flow to Operating Cash Flow Ratio-0.17
Cash Flow Coverage Ratio-33.08
Short Term Coverage Ratio-33.08
Capital Expenditure Coverage Ratio0.86
Dividend Paid and Capex Coverage Ratio0.82
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at -0.23%, highlights its total liabilities relative to assets. An interest coverage of 105.69 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio-0.23%
Total Debt to Capitalization-0.25%
Interest Coverage105.69
Cash Flow to Debt Ratio-33.08
Company Equity Multiplier1.09

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 6.77, provides a glimpse into top-line earnings distributed across each share. Net income per share, 2.00, reflects the portion of profit attributed to each share. The book value per share, 23.84, represents the net asset value distributed per share, while the tangible book value per share, 21.06, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share6.77
Net Income Per Share2.00
Book Value Per Share23.84
Tangible Book Value Per Share21.06
Shareholders Equity Per Share23.84
Interest Debt Per Share0.02
Capex Per Share-1.96

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 43.72%, indicates top-line expansion, while the gross profit growth, 42.30%, reveals profitability trends. EBIT growth, 42.11%, and operating income growth, 42.11%, offer insights into operational profitability progression. The net income growth, 45.22%, showcases bottom-line expansion, and the EPS growth, 45.99%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth43.72%
Gross Profit Growth42.30%
EBIT Growth42.11%
Operating Income Growth42.11%
Net Income Growth45.22%
EPS Growth45.99%
EPS Diluted Growth45.26%
Weighted Average Shares Growth-0.10%
Weighted Average Shares Diluted Growth0.01%
Dividends per Share Growth-42.54%
Operating Cash Flow Growth55.74%
Free Cash Flow Growth107.58%
5-Year Revenue Growth per Share66.85%
3-Year Revenue Growth per Share22.36%
5-Year Operating CF Growth per Share17.25%
3-Year Operating CF Growth per Share11.31%
5-Year Net Income Growth per Share61.29%
3-Year Net Income Growth per Share-5.00%
5-Year Shareholders Equity Growth per Share550.99%
3-Year Shareholders Equity Growth per Share15.89%
5-Year Dividend per Share Growth per Share82.33%
3-Year Dividend per Share Growth per Share1.65%
Receivables Growth48.17%
Inventory Growth14.59%
Asset Growth7.23%
Book Value per Share Growth6.53%
Debt Growth-100.00%
R&D Expense Growth31.83%
SGA Expenses Growth39.42%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,207,278,808.47, captures the company's total value, considering both debt and equity. Income quality, 0.98, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.04, gauges operational efficiency, while the research and development to revenue, 12.47%, highlights investment in innovation. The ratio of intangibles to total assets, 10.51%, indicates the value of non-physical assets, and capex to operating cash flow, -99.47%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value3,207,278,808.47
Income Quality0.98
Sales General and Administrative to Revenue0.04
Research and Development to Revenue12.47%
Intangibles to Total Assets10.51%
Capex to Operating Cash Flow-99.47%
Capex to Revenue-28.88%
Capex to Depreciation-662.93%
Graham Number32.73
Return on Tangible Assets8.43%
Graham Net Net48.33
Working Capital1,103,145,006
Tangible Asset Value1,436,874,876
Net Current Asset Value1,075,559,187
Average Receivables39,624,064.5
Average Payables18,836,272
Average Inventory37,375,990.5
Days Sales Outstanding37
Days Payables Outstanding50
Days of Inventory On Hand112
ROIC8.29%
ROE0.08%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.00, and the price to book ratio, 2.00, reflect the market's valuation relative to the company's book value. The price to sales ratio, 7.28, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -145.49, and price to operating cash flows, 24.03, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.00
Price to Book Ratio2.00
Price to Sales Ratio7.28
Price Cash Flow Ratio24.03
Enterprise Value Multiple30.42
Price Fair Value2.00
Price to Operating Cash Flow Ratio24.03
Price to Free Cash Flows Ratio-145.49
Price to Tangible Book Ratio2.68
Enterprise Value to Sales6.94
Enterprise Value Over EBITDA18.37
EV to Operating Cash Flow23.90
Earnings Yield3.12%
Free Cash Flow Yield0.02%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Nanjing Vishee Medical Technology Co., Ltd (688580.SS) on the SHH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 25.820 in 2024.

What is the ticker symbol of Nanjing Vishee Medical Technology Co., Ltd stock?

The ticker symbol of Nanjing Vishee Medical Technology Co., Ltd stock is 688580.SS.

What is company IPO date?

IPO date of Nanjing Vishee Medical Technology Co., Ltd is 2020-07-21.

What is company current share price?

Current share price is 47.440 CNY.

What is stock market cap today?

The market cap of stock today is 3231729123.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 686.